Profit

Cipla Receives Inspection Report From US Regulator For Indore Facility

 Share
EMAIL
PRINT
COMMENTS
Cipla Receives Inspection Report From US Regulator For Indore Facility

An establishment inspection report is given after successful completion of inspection by the FDA.


New Delhi: Drug major Cipla on Wednesday said it has received an establishment inspection report (EIR) from the US health regulator for its Indore plant after completion of inspection there.

The company has "received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Indore facility indicating formal closure of the USFDA inspection conducted in July/August, 2015", Cipla said in a filing to the BSE.

EIR is given after successful completion of inspection by the US regulator. 


Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.

NDTV Beeps - your daily newsletter

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Top